Yellow-fever-vaccine
暂无分享,去创建一个
[1] W. Popp,et al. Effects of yellow fever vaccination , 2001, The Lancet.
[2] V. Adhiyaman,et al. Effects of yellow fever vaccination , 2001, The Lancet.
[3] F. Laurencet,et al. Effects of yellow fever vaccination , 2001, The Lancet.
[4] M. Cetron,et al. Advanced age a risk factor for illness temporally associated with yellow fever vaccination. , 2001, Emerging infectious diseases.
[5] T. Monath,et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases , 2001, The Lancet.
[6] M. Cetron,et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases , 2001, The Lancet.
[7] W. Rawlinson,et al. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine , 2001, The Lancet.
[8] J. H. Bauer,et al. The transmission of yellow fever to Macacus rhesus , 2001 .
[9] P. Mortimer,et al. The use of yellow fever virus modified by in vitro cultivation for human immunization , 2000, Reviews in medical virology.
[10] Matthias Niedrig,et al. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection , 1998, Journal of medical virology.
[11] N. Karabatsos,et al. First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. , 1998, The American journal of tropical medicine and hygiene.
[12] G. Hartmann,et al. In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination. , 1998, The Journal of infectious diseases.
[13] T. Monath,et al. Does restricted distribution limit access and coverage of yellow fever vaccine in the United States? , 1998, Emerging infectious diseases.
[14] F. Adu,et al. Live viral vaccine potency: an index for assessing the cold chain system. , 1996, Public health.
[15] V. Stepanets,et al. [Effective knowledge propaganda is the chief strategy for preventing HIV infection among adolescents]. , 1994, Likars'ka sprava.
[16] N. Miller,et al. Are childhood immunization programmes in Australia at risk? Investigation of the cold chain in the Northern Territory. , 1994, Bulletin of the World Health Organization.
[17] Iu P Spizhenko. [Prevention of the spread of AIDS in the Ukrainian SSR]. , 1988, Vrachebnoe delo.
[18] E. Schiff,et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. , 1987, The New England journal of medicine.
[19] R. A. Morrissey,et al. Inadequate poliovirus immunity levels in immunized Illinois children. , 1973, American journal of diseases of children.
[20] J. Fox,et al. ENCEPHALITIS IN MAN FOLLOWING VACCINATION WITH 17 D YELLOW FEVER VIRUS , 1942 .
[21] H. H. Smith,et al. Yellow Fever Vaccination with Cultured Virus (17D) without Immune Serum 1 , 1938 .
[22] Max Theiler,et al. THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION , 1937, The Journal of experimental medicine.
[23] S. Kitchen,et al. Yellow Fever accidentally Contracted in the Laboratory. A Study of Seven Cases. , 1931 .
[24] J. H. Bauer,et al. THE TRANSMISSION OF YELLOW FEVER TO MACACUS RHESUS: PRELIMINARY NOTE , 1928 .